NCBiotech Company Directory

A comprehensive listing of North Carolina's life science industry

Mapping large numbers of results may take a few moments.

Search Results

Showing 1 - 16 of 16 results found.

Activity Company Description Location
Company Archerfish Co. Activity: Research and Development Research and Development Company Description Archerfish develops small molecule drugs to reduce tissue fibrosis and corneal scarring. Location Cary
Company Atsena Therapeutics Inc. Activity: Research and Development Research and Development Company Description Atsena Therapeutics is developing ocular gene therapies to reverse or prevent blindness. Location Durham
Company Caeregen Therapeutics LLC Activity: Research and Development Research and Development Company Description Caeregen Therapeutics develops therapies which repair, restore, and protect damaged and diseased tissues by reactivating the pathways and signaling which accompany normal cellular and tissue development. Caeregen is developing Noregen, a recombinant protein mimetic of human norrin-derived growth factor for the potential treatment of retinal-related vision loss. Location Chapel Hill
Company Drive Therapeutics LLC Activity: Research and Development Research and Development Company Description Drive Therapeutics is developing therapeutics for wet age-related macular degeneration (wAMD) and diabetic retinopathy/diabetic macular edema (DR/DME). Location Research Triangle Park
Company Eclipse Life Sciences Inc. Activity: Research and Development Research and Development Company Description Eclipse Life Sciences is developing therapeutic compounds to treat front-of-the-eye diseases, such as uveitis and dry eye, as well as back-of-the-eye diseases, such as wet or dry macular degeneration or diabetic retinopathy. Location Research Triangle Park
Company EternaTear Inc. Activity: Research and Development Research and Development Company Description EternaTear had developed a novel artificial tear formulation that provides long lasting ocular lubrication to offer relief from dry eye. Location Raleigh
Company Eyedesis Biosciences LLC Activity: Research and Development Research and Development Company Description Eyedesis Biosciences is developing a small-molecule macrophage inhibitor for the treatment of neovascular age related macular degeneration. Location Chapel Hill
Company Ideal Health Biotechnology LLC Activity: Research and Development Research and Development Company Description Ideal Health Biotechnology researches and develops dietary supplements made from plant-based compounds, including products derived from grape seed extract and algae for digestion, eye disease and diabetes. Location Kannapolis
Company Immunovant Inc. Activity: Research and Development Research and Development Company Description Immunovant is a clinical-stage biopharmaceutical company developing treatments for autoimmune diseases. Location Durham
Company KlearOptix Inc. Activity: Contract Research and Testing Contract Research and Testing Company Description KlearOptix develops materials for high oxygen permeable silicone hydrogel, rigid gas permeable (RGP), and hybrids for contact lens applications. Location Kannapolis
Company Lumedica Vision Inc. Activity: Research and Development Research and Development Company Description Lumedica Vision develops Optical Coherence Tomography (OCT) systems for research and clinical applications. Location Durham
Company Nicox Ophthalmics Activity: Research and Development Research and Development Company Description Nicox Ophthalmics develops therapeutics from a proprietary nitric-oxide research platform to help maintain vision and improve ocular health. Location Durham
Company Oculus Research Inc. Activity: Contract Research and Testing Contract Research and Testing Company Description Oculus Research specializes in ophthalmic research studies, including glaucoma/ocular hypertension, adenoviral and bacterial conjunctivitis, blepharitis, keratoconjunctivitis sicca (dry eye), myopia control, presbyopia, and devices such as contact lenses. Location Garner
Company Opus Genetics Inc. Activity: Research and Development Research and Development Company Description Opus Genetics is a clinical-stage gene therapy company developing treatments for inherited retinal diseases. Location Research Triangle Park
Company RainBio Inc. Activity: Research and Development Research and Development Company Description RainBio is developing AAV (adeno-associated virus) gene therapy corneal treatments to address the unmet need of treatment of rare corneal blinding diseases. Location Raleigh
Company Zoion Pharma Inc. Activity: Research and Development Research and Development Company Description Zoion Pharma develops drugs for veterinary disorders. Zoion's lead product is an epithelial sodium channel blocker compound to treat canine keratoconjunctivitis sicca (KCS) or dry eye. Location Raleigh